I like the Melton deal better than I do the massive dilution and warrant deal which could easily be attained at these current prices.
Go check out ADH, Adherex's financials. They have 175 million out, around 18-20 million in the bank, their VTA is moving into Phase Ib/II and the PPS is .30. That's thirty cents. If PPHM investors want to do a massive dilution at these current price levels, then let me go on and sell. Adherex diluted massively after 9/11, with Orbimed and HBM Bioventures, and another IB on bad terms. Those folks are not happy about the current PPS, they know it's a problem. They blame it on previous mismanagement and venture capital being scarce after 9/11.
PPHM needs to get Tarvacin enrolled quickly and license one of the VTAs in the near future. Wish someone would sign up for 2C3.
katie....